Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin’s lymphoma patients receiving autologous hematopoietic stem cell transplantation

By Lee Ming-Yang  

Annals of Hematology, Vol. 87, Iss. 4, 2008-04 ,pp. : 285-289

Springer Publishing Company

Access to resources Recommend Favorite

Predictive value of ¹⁸F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation

By Qiao Wenli   Zhao Jinhua   Wang Chun   Wang Taisong   Xing Yan  

Hematology, Vol. 15, Iss. 1, 2010-02 ,pp. : 21-27

Maney Publishing

Access to resources Recommend Favorite

Outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma patients in a centre from Turkey

By Sucak Gülsan Türköz   Çakar Merih Kızıl   Suyanı Elif   Akı Zeynep   Altındal Şermin   Acar Kadir  

Hematology, Vol. 18, Iss. 5, 2013-09 ,pp. : 269-276

Maney Publishing

Access to resources Recommend Favorite

Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non-Hodgkin's lymphoma patients

By Singh R.K.   Varney M.L.   Ino K.   Vose J.M.   Bierman P.J.   Talmadge J.E.  

Experimental Hematology, Vol. 28, Iss. 5, 2000-05 ,pp. : 499-507

Elsevier

Access to resources Recommend Favorite

High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin’s lymphoma

By Ianni Mauro Di   Ballanti Stelvio   Iodice Giuseppe   Reale Antonia   Falzetti Franca   Minelli Olivia   Serio Gabriella   Martelli Massimo F   Dammacco Franco   Vacca Angelo   Ria Roberto  

Hematology, Vol. 17, Iss. 1, 2012-01 ,pp. : 23-27

Maney Publishing

Access to resources Recommend Favorite